Summary:
Help Develop the Next Life-Saving Vaccine—Volunteer Now
- The purpose of this trial is to see how your immune system
(your body’s natural defense that fights off germs and keeps you healthy)
reacts to an investigational vaccine against Sudan virus disease.
- In humans, Sudan Ebolavirus (SUDV) is responsible for
causing Sudan Virus Disease (SVD), formerly known as Ebola hemorrhagic fever.
It spreads through human-to-human transmission, with infection resulting from
direct contact with blood, secretions, organs, or other bodily fluids of
infected people, and indirect contact with contaminated environments. The
average case fatality rate of SVD is around 50%.
- As there are currently no approved vaccines or
therapeutics to treat individuals infected with SUDV, a vaccine with rapid and
durable protective immunity would be desirable for populations in areas of the
world where outbreaks occur sporadically
Qualified Participants Must:
• Healthy Adults
•
Be 18 to 70 years old
•
Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician
•
Be available and willing to commit to the trial visit structure - You will be asked to come to our clinic for 8 outpatient visits and 2 follow-up phone calls.
Qualified Participants May Receive:
Eligible participants will receive
trial related care and assessments at no cost and may be compensated up to
$1,250 for trial related time.